Nebenwirkungen · Hycamtin
HYCAMTIN 0.25 mg hard capsules HYCAMTIN 1 mg hard capsules · Abschnitt 4.8 · PDF-Seite 20
HOS-086093 · Präparat HOS-083256
Infections and infestations Very common Infection Common Sepsis1 Blood and lymphatic system disorders Very common Febrile neutropenia, neutropenia (see “Gastrointestinal disorders”), thrombocytopenia, anaemia, leucopenia Common Pancytopenia Not known Severe bleeding (associated with thrombocytopenia) Immune system disorders Common Hypersensitivity reaction including rash Rare Anaphylactic reaction, angioedema, urticaria Metabolism and nutrition disorders Very common Anorexia (which may be severe) Respiratory, thoracic and mediastinal disorders Rare Interstitial lung disease (some cases have been fatal) Gastrointestinal disorders Very common Nausea, vomiting and diarrhoea (all of which may be severe), which may lead to dehydration (see sections 4.2 and 4.4) Common Abdominal pain2, constipation, mucositis, dyspepsia Not known Gastrointestinal perforation Hepatobiliary disorders Common Hyperbilirubinaemia Skin and subcutaneous tissue disorders Very common Alopecia Common Pruritus General disorders and administration site conditions Very common Fatigue Common Asthenia, pyrexia, malaise
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-20T15:26:00Z · SHA-256 b5faba0cb8dc430e883615daec0cf15a62742b0008cf3a57c33ebf39c2a0a4b9 · Passage 3de2161c9430ee66226befc0d0c0ac1122ab74ca1640d21f1be743e9ba29a397 · Zeichen 917–2252 im Abschnitt